CBD, hemp oil, and other hemp products are quickly becoming a common household staple these days, and as our use of these products expands, thankfully so does the research. 

A bit about cannabinoids:

We’ve talked about cannabinoids, the natural chemical compounds secreted by cannabis flowers. Mostly, we hear about THC or CBD, two widely known cannabinoids. These are the compounds that work with our endocannabinoid system and the reason so many people report experiencing relief from a variety of symptoms.

Cannabinoids work by binding to receptor sites; some bind to receptors in the brain (CB-1), and some bind to receptors throughout the body (CB-2). Depending on which receptor a cannabinoid binds to, different effects can be observed.

Hemp contains at least 85 cannabinoids, and one cannabinoid that many people are just getting familiar with is CBG or Cannabigerol. And although some of us are new to CBG, it was discovered by researchers in the 1960’s.

What exactly is CBG?

CBG is pretty special among cannabinoids, because it’s the precursor from which all other cannabinoids are synthesized. In fact it’s sometimes called the “mother” of cannabinoids. Researchers are studying this “mother” and the findings are pretty promising. 

The National Center for Complementary and Integrative Health announced in 2018 that it would be researching CBG for its effects on pain. 

Some research indicates that CBG may reduce eye pressure related to glaucoma, and has been shown to block the growth of some cancer cells in mice. In a 2015 study, CBG showed promise in mice with Huntington’s disease.

Other possible benefits that researchers are finding with CBD research are:

With all of this information, and new studies popping up all the time, we’re excited to learn more about CBG. You can look forward to a new high CBG strain or two coming from us in the near future! Stay tuned, and we’ll be sure to keep you in the loop.

In the meantime, check out our sources for a lot more info on CBG: